CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 1,301–1,400번째 · 14 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100694Anti-C5(tesidolumab biosimilar) mAb
  2. BME100694BBiotinylated Anti-C5(tesidolumab biosimilar) mAb
  3. BME100695Anti-BTLA(tifcemalimab biosimilar) mAb
  4. BME100695BBiotinylated Anti-BTLA(tifcemalimab biosimilar) mAb
  5. BME100696Anti-MAPT(tilavonemab biosimilar) mAb
  6. BME100696BBiotinylated Anti-MAPT(tilavonemab biosimilar) mAb
  7. BME100697Anti-IL23A(tildrakizumab biosimilar) mAb
  8. BME100697BBiotinylated Anti-IL23A(tildrakizumab biosimilar) mAb
  9. BME100698Anti-TNFRSF10B(tilogotamab biosimilar) mAb
  10. BME100698BBiotinylated Anti-TNFRSF10B(tilogotamab biosimilar) mAb
  11. BME100699Anti-AXL(tilvestamab biosimilar) mAb
  12. BME100699BBiotinylated Anti-AXL(tilvestamab biosimilar) mAb
  13. BME100700Anti-PD-1(tislelizumab biosimilar) mAb
  14. BME100700BBiotinylated Anti-PD-1(tislelizumab biosimilar) mAb
  15. BME100701Anti-Trop2(tizetatug biosimilar) mAb
  16. BME100701BBiotinylated Anti-Trop2(tizetatug biosimilar) mAb
  17. BME100702Anti-EGFR(tomuzotuximab biosimilar) mAb
  18. BME100702BBiotinylated Anti-EGFR(tomuzotuximab biosimilar) mAb
  19. BME100703Anti-PD-1(toripalimab biosimilar) mAb
  20. BME100703BBiotinylated Anti-PD-1(toripalimab biosimilar) mAb
  21. BME100704Anti-IL33(torudokimab biosimilar) mAb
  22. BME100704BBiotinylated Anti-IL33(torudokimab biosimilar) mAb
  23. BME100705Anti-IL33(tozorakimab biosimilar) mAb
  24. BME100705BBiotinylated Anti-IL33(tozorakimab biosimilar) mAb
  25. BME100706Anti-CD131(trabikibart biosimilar) mAb
  26. BME100706BBiotinylated Anti-CD131(trabikibart biosimilar) mAb
  27. BME100707Anti-CTLA-4(tremelimumab biosimilar) mAb
  28. BME100707BBiotinylated Anti-CTLA-4(tremelimumab biosimilar) mAb
  29. BME100708Anti-GDF8(trevogrumab biosimilar) mAb
  30. BME100708BBiotinylated Anti-GDF8(trevogrumab biosimilar) mAb
  31. BME100709Anti-TNFSF15(tulisokibart biosimilar) mAb
  32. BME100709BBiotinylated Anti-TNFSF15(tulisokibart biosimilar) mAb
  33. BME100710Anti-LAG3(tuparstobart biosimilar) mAb
  34. BME100710BBiotinylated Anti-LAG3(tuparstobart biosimilar) mAb
  35. BME100711Anti-IL17A(turenkibart biosimilar) mAb
  36. BME100711BBiotinylated Anti-IL17A(turenkibart biosimilar) mAb
  37. BME100712Anti-CTLA-4(tuvonralimab biosimilar) mAb
  38. BME100712BBiotinylated Anti-CTLA-4(tuvonralimab biosimilar) mAb
  39. BME100713Anti-CD20(ublituximab biosimilar) mAb
  40. BME100713BBiotinylated Anti-CD20(ublituximab biosimilar) mAb
  41. BME100714Anti-CD200R1(ucenprubart biosimilar) mAb
  42. BME100714BBiotinylated Anti-CD200R1(ucenprubart biosimilar) mAb
  43. BME100715Anti-HGF(umikibart biosimilar) mAb
  44. BME100715BBiotinylated Anti-HGF(umikibart biosimilar) mAb
  45. BME100716Anti-NPT2B(upinitatug biosimilar) mAb
  46. BME100716BBiotinylated Anti-NPT2B(upinitatug biosimilar) mAb
  47. BME100717Anti-4-1BB(urelumab biosimilar) mAb
  48. BME100717BBiotinylated Anti-4-1BB(urelumab biosimilar) mAb
  49. BME100718Anti-APP(usilnetug biosimilar) mAb
  50. BME100718BBiotinylated Anti-APP(usilnetug biosimilar) mAb
  51. BME100719Anti-IL6(vamikibart biosimilar) mAb
  52. BME100719BBiotinylated Anti-IL6(vamikibart biosimilar) mAb
  53. BME100720Anti-IL5(varokibart biosimilar) mAb
  54. BME100720BBiotinylated Anti-IL5(varokibart biosimilar) mAb
  55. BME100721Anti-IGF-1R(veligrotug biosimilar) mAb
  56. BME100721BBiotinylated Anti-IGF-1R(veligrotug biosimilar) mAb
  57. BME100722Anti-BTLA(venanprubart biosimilar) mAb
  58. BME100722BBiotinylated Anti-BTLA(venanprubart biosimilar) mAb
  59. BME100723Anti-CRLF2(verekitug biosimilar) mAb
  60. BME100723BBiotinylated Anti-CRLF2(verekitug biosimilar) mAb
  61. BME100724Anti-TIM3(verzistobart biosimilar) mAb
  62. BME100724BBiotinylated Anti-TIM3(verzistobart biosimilar) mAb
  63. BME100725Anti-IL1A(vilamakitug biosimilar) mAb
  64. BME100725BBiotinylated Anti-IL1A(vilamakitug biosimilar) mAb
  65. BME100726Anti-CTLA-4(vilastobart biosimilar) mAb
  66. BME100726BBiotinylated Anti-CTLA-4(vilastobart biosimilar) mAb
  67. BME100727Anti-C5(vilobelimab biosimilar) mAb
  68. BME100727BBiotinylated Anti-C5(vilobelimab biosimilar) mAb
  69. BME100728Anti-GDF15(visugromab biosimilar) mAb
  70. BME100728BBiotinylated Anti-GDF15(visugromab biosimilar) mAb
  71. BME100729Anti-NPR1(vixticibart biosimilar) mAb
  72. BME100729BBiotinylated Anti-NPR1(vixticibart biosimilar) mAb
  73. BME100730Anti-B7-H3(vobramitamab biosimilar) mAb
  74. BME100730BBiotinylated Anti-B7-H3(vobramitamab biosimilar) mAb
  75. BME100731Anti-IL2RA(vopikitug biosimilar) mAb
  76. BME100731BBiotinylated Anti-IL2RA(vopikitug biosimilar) mAb
  77. BME100732Anti-IL17A(vunakizumab biosimilar) mAb
  78. BME100732BBiotinylated Anti-IL17A(vunakizumab biosimilar) mAb
  79. BME100733Anti-IL17A(xeligekimab biosimilar) mAb
  80. BME100733BBiotinylated Anti-IL17A(xeligekimab biosimilar) mAb
  81. BME100734Anti-BTLA(zadoprubart biosimilar) mAb
  82. BME100734BBiotinylated Anti-BTLA(zadoprubart biosimilar) mAb
  83. BME100735Anti-CTLA-4(zalifrelimab biosimilar) mAb
  84. BME100735BBiotinylated Anti-CTLA-4(zalifrelimab biosimilar) mAb
  85. BME100736Anti-TGM2(zampilimab biosimilar) mAb
  86. BME100736BBiotinylated Anti-TGM2(zampilimab biosimilar) mAb
  87. BME100737Anti-PACR(zelminemab biosimilar) mAb
  88. BME100737BBiotinylated Anti-PACR(zelminemab biosimilar) mAb
  89. BME100738Anti-PD-1(zeluvalimab biosimilar) mAb
  90. BME100738BBiotinylated Anti-PD-1(zeluvalimab biosimilar) mAb
  91. BME100739Anti-APRIL(zigakibart biosimilar) mAb
  92. BME100739BBiotinylated Anti-APRIL(zigakibart biosimilar) mAb
  93. BME100740Anti-IL6(ziltivekimab biosimilar) mAb
  94. BME100740BBiotinylated Anti-IL6(ziltivekimab biosimilar) mAb
  95. BME100741Anti-PD-1(zimberelimab biosimilar) mAb
  96. BME100741BBiotinylated Anti-PD-1(zimberelimab biosimilar) mAb
  97. BME100742Anti-CD163(zovostotug biosimilar) mAb
  98. BME100742BBiotinylated Anti-CD163(zovostotug biosimilar) mAb
  99. BME100743Anti-Canine IL31RA(nolavetbart biosimilar) mAb
  100. BME100743BBiotinylated Anti-Canine IL31RA(nolavetbart biosimilar) mAb